Author:
Moureau-Zabotto L.,Bouchet C.,Cesari D.,Uzan S.,Lefranc J.P.,Antoine M.,Genestie C.,Deniaud-Alexandre E.,Bernaudin J.F.,Touboul E.,Fleury-Feith J.
Subject
Radiology, Nuclear Medicine and imaging,Oncology
Reference37 articles.
1. Prognostic and predictive value of thymidine labelling index in breast cancer;Amadori;Breast Cancer Res. Treat.,1998
2. Clinical practice guidelines for the use of tumor markers in breast and colorectal cancer. Adopted on May, 17, 1996 by the American Society of Clinical Oncology;Anonymous;J. Clin. Oncol.,1996
3. 1997 update of recommendations for the use of tumor markers in breast and colorectal cancer. Adopted on November, 7, 1997 by the American Society of Clinical Oncology;Anonymous;J. Clin. Oncol.,1998
4. S-phase fraction combined with other patient and tumor characteristics for the prognosis of node-negative, estrogen-receptor-positive breast cancer;Bryant;Breast Cancer Res. Treat.,1998
5. The prognostic significance of DNA flow cytometry in breast cancer: results from 881 patients treated in a single centre;Camplejohn;Br. J. Cancer,1995
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献